Rapport Therapeutics, Inc. · NASDAQ:RAPP
Ceesay Abraham sold 2,210 Rapport Therapeutics, Inc. shares (Form 4)
Traded Oct 21, 2026 · Filed Oct 23, 2026
On Oct 21, 2026, Ceesay Abraham (Director, Chief Executive Officer) sold 2,210 Rapport Therapeutics, Inc. shares at US$29.16 for US$64,448 under a trading plan, leaving 450,035 shares. Filed Oct 23, 2026 (Form 4).
- Sold
- 2,210 shares
- Price
- US$29.16
- Value
- US$64,448
- Holding after
- 450,035 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Common Stock | Sale | 2,210 | US$29.16 | 450,035 | Direct |
Source
Download original · View original at SEC
Related
- Rapport Therapeutics, Inc.
- Ceesay Abraham
- Rapport Therapeutics, Inc. shareholders
- Form 4 · Ceesay Abraham · Oct 8, 2026
- Form 4 · Ceesay Abraham · Sep 24, 2026
- Form 4 · Ceesay Abraham · Sep 9, 2026
- Form 4 · Ceesay Abraham · Aug 26, 2026
- Form 4 · Ceesay Abraham · Aug 12, 2026
- Form 4 · Sanchez Ramiro · Oct 23, 2026
- Form 4 · Maraganore John · Oct 22, 2026
- Form 4 · Silva Paul M · Oct 22, 2026
- Form 4 · Young Wendy B. · Oct 22, 2026
- Form 4 · Paul Steven M · Oct 22, 2026